TECNIC Bioprocess Solutions

www.tecnic.eu ↗ ·Riudarenes ·Other

TECNIC Bioprocess Solutions is a Riudarenes (Girona)-based manufacturer of bioprocess equipment for biopharmaceutical companies and research organisations producing biomolecules such as monoclonal antibodies, vaccines, recombinant proteins and cell and gene therapies. It designs and builds bioreactors, tangential flow filtration and perfusion systems, and control software that scale from the laboratory to industrial production, and it pairs equipment sales with recurring single-use consumables such as bags and flowkits. Founded in 2011 by Manel Moyano Cudinach, the company reported revenue above €20 million in 2024 with more than 90% generated internationally through 24 distributors across Europe, Asia and the Middle East, and it works with customers including the Serum Institute of India. In 2022 ICF Capital Expansió II invested €2.5 million in equity to expand its production and R&D facilities and support international growth, following earlier backing from Keiretsu Forum, and in 2025 the company turned down an acquisition offer valued at more than €100 million.

Founded
2011
Founders
1
Total funds raised
€2.5M
Rounds
1
Investors
2
Last round
Mar 2022
SectorsBiotechnology, Bioprocessing, Life Science Tools, Biomanufacturing Equipment Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Suggest a correction

Founders

Manel Moyano Cudinach
Founder & CEO

Global models 5

Univercells
Its Univercells Technologies arm designs and sells bioreactor and bioprocessing systems that scale from lab to commercial production, with recurring single-use consumables.
$400MComparable
Cellares
United States · www.cellares.com ↗
Builds automated closed bioprocessing hardware for cell therapy manufacturing, sold with single-use consumable cartridges, to biopharma producers.
$355MComparable
Ori Biotech
United Kingdom · oribiotech.com ↗
Sells a cell and gene therapy manufacturing platform (instrument plus control software) with recurring single-use consumables to therapy developers and manufacturers.
$140MComparable
Culture Biosciences
Offers bioreactor systems and bioprocess development software to biopharma and biomanufacturing companies, but monetises more through a cloud-lab service model.
$100MComparable
Multiply Labs
United States · www.multiplylabs.com ↗
Makes robotic bioprocessing equipment that automates cell therapy manufacturing, sold to biopharma companies and research organisations.
$40MComparable

In the same niche 26 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 2

Open as list →

Funding rounds 1

DateRoundAmountLead
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list